EIN 22-2803458

Mtfbiologics (MTF)

IRS 501(c) type
501(c)(3)
Num. employees
1,452
City
Year formed
1987
Most recent tax filings
2019-12
NTEE code, primary
Description
As a non-profit service organization, Musculoskeletal Transplant Foundation is dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families.
Also known as...
Musculoskeletal Transplant Foundation

Program areas at MTF

Mtf provides allograft tissues to the medical community. Since its inception in 1987, mtf, the nation's leading tissue bank, has received tissue donations from over 140,000 donors. In 2019, mtf recovered tissue from over 5,500 donors for use in Musculoskeletal and bone allograft applications, over 5,300 donors for use in burn, general, and plastic surgery applications, over 1,200 donors for use in woundcare applications and over 900 donors for organs and tissues for research. Overall, mtf distributed more than 490,000 units of allograft tissue during 2019. Mtf continued to donate allograft tissues for research, medical, and educational purposes. In collaboration with surgeons, mtf continues to develop innovative tissue forms, focused on solving real-world, clinical problems. Mtf has also continued its efforts to provide special research tissue for research performed by members of the armed forces institute of regenerative medicine (afirm), an organization dedicated to developing medical therapies for wounded soldiers. In december of 2019, mtf provided nearly 500 life saving, skin-for-burn grafts to assist in the international effort to treat victims injured in the volcano eruption in new zealand. This effort was accomplished through collaboration with the donor tissue bank of victoria in australia. In 2019, mtf continued to increase tissue utilization and placement of tissue forms in the orthopedic, plastic and reconstructive surgery, and wound care markets. In the orthopedics market, mtf launched quickgraft, a pre-sutured tendon for use in sports medicine procedures. This technology allows mtf and surgeon partners to honor the donated gift by increasing the predictability of surgical procedures for the patient all the while using tendons that were not previously of high demand. Mtf also continued to increase its utility of the mops osteochondral preservation technology, providing higher quality tissue for doctors and patients, while reducing the time to match a tissue donation to a recipient. Mtf also began to distribute cc+, a cortical-cancellous bone void filler that allows the donated tissue to reach more recipients without compromising quality or effectiveness. Furthermore, mtf launched a new cortical fiber based bone void filler, fiber fuse which possesses osteo-inductive, osteo-conductive potential and excellent handling properties. In plastic and reconstructive surgery (prs), mtf lauched flexhd pre, an innovative tissue form, designed to allow surgeons greater options for breast reconstruction procedures following mastectomy. The mtf prs division also saw an increased use of renuva, an off-the-shelf adipose matrix, for reconstruction and treatment of small volume defects where host fat has either decreased or been degraded or lost due to trauma or disease. Mtf's wound care division developed and launched somagen, a tissue form designed to increase wound coverage area, while still decreasing the time to closure. Additionally, leneva an off-the-shelf soft tissue adipose matrix was launched to treat fat pad atrohpe and avoid the development of ulcers. Mtf also continued expanding the distribution of its wound care portfolio to more recipients in the va and public hospitals throughout the year. This was achieved through the publication of more positive, peer reviewed, clinical outcomes papers coupled with the acceptance of the mtf wounce care tissue forms by more third party insurance providers as medically necessary. Mtf continued to expand its clinical study portfolio, increasing its compendium of clinical data for expanded reimbursement in wound care and breast reconstruction. Mtf continued its prospective randomized clinical trial for flexhd pliable acellular dermal matrix used for breast reconstruction following mastectomy. In the wound care market, clinical studies and research data have provided the information for mtf to attain coverage for approximately 73% of all covered american lives in 2019. Mtf continued its support of the american society of plastic surgeons (asps) and the plastic surgery Foundation (psf) which provides opportunites for surgeons to perform allograft based research to advance the science of allogarft use in plastic/reconstructive procedures. Mtf also remains committed to supporting breast reconstruction awareness (bra) day each year and includes education for both patients and surgeons on the options available today for women, helping to ensure survivors' rights to make an informed decision. Mtf also continued its financial pledge of (1m over five years) to support biologic research through the plastic surgery Foundation (psf). Mtf's mission is to save and heal lives by honoring the donated gift, serving patients and advancing science. For individual stories about donor families, please visit mtf biologics website at httpswwwmtfbiologicsorgwhoweserve... community/donors-families. Stories about recipients are also available on the website at httpswwwmtfbiologicsorgwhoweserve... community/recipients and on the youtube channel at httpswwwyoutubecomuserthemtf1

Form 990s for MTF

Fiscal year endingDate received by IRSFormPDF link
2019-122021-04-02990View PDF
2018-122020-02-14990View PDF
2017-122019-03-15990View PDF
2016-122018-03-14990View PDF
2015-122017-04-05990View PDF
...and 6 more Form 990s

Who funds Mtfbiologics (MTF)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Texas Health DallasGeneral Support$393,045

Grants made by MTF

GranteeGrant descriptionAmount
Stevens Institute of Technology (SIT)Career Development$200,000
 Subscribe to view█████ ████$999,999
 Subscribe to view█████ ████$999,999
 Subscribe to view█████ ████$999,999
 Subscribe to view█████ ████$999,999
...and 55 more grants made

Financials for MTF

RevenuesFYE 12/2019
Total grants, contributions, etc.$890,250
Program services$452,689,157
Investment income and dividends$987,643
Tax-exempt bond proceeds$0
Royalty revenue$839,956
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$-1,464,445
Miscellaneous revenues$6,886,071
Total revenues$460,828,632

Personnel at MTF

NameTitleCompensation
Bruce W StroeverPresident and Chief Executive Officer$859,507
Joe YaccarinoPresident and Chief Executive Officer / Executive Vice President , Operations
Joseph A YaccarinoPresident and Chief Executive Officer$643,159
 Subscribe to viewTreasurer and Chief Financial Officer / Board Member$529,212
 Subscribe to viewVice President Orthopedi$410,486
...and 5 more key personnel

Organizations like MTF

OrganizationLocationRevenue
Be the MatchMinneapolis, MN$445,357,123
National Multiple Sclerosis SocietyNew York, NY$196,889,837
Juvenile Diabetes Research Foundation (JDRF)New York, NY$239,329,465
Cystic Fibrosis FoundationBethesda, MD$605,778,425
The Leukemia and Lymphoma SocietyRye Brook, NY$396,221,152
American Cancer Society (ACS)Atlanta, GA$720,131,846
Alzheimer's AssociationChicago, IL$389,665,878
The Michael J. Fox Foundation for PARKINSON'S ResearchNew York, NY$161,693,487
Scripps Research InstituteLa Jolla, CA$412,183,981
Population Services International (PSI)Washington, DC$493,614,976
Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, CA$122,956,459
Fred Hutch (FHCRC)Seattle, WA$698,140,612
The Broad InstituteCambridge, MA$536,846,609
AlloSourceCentennial, CO$146,066,508
LifeLink FoundationTampa, FL$123,638,327
New York Genome Center (NYGC)New York, NY$128,448,950
American Society of Clinical Oncology (ASCO)Alexandria, VA$162,711,421
Elizabeth Glaser Pediatric Aids FoundationWashington, DC$202,227,730
Weizmann Institute of ScienceIsrael, $414,515,393
Henry M Jackson Foundation For The Advancement of Military MedicineBethesda, MD$495,039,325
Purdue Research Foundation (PRF)West Lafayette, IN$212,466,003
Cold Spring Harbor LaboratoryCold Spring Harbor, NY$307,604,088
Lifenet HealthVirginia Beach, VA$418,564,024
Beckman Research Institute of the City of Hope (BRI)Duarte, CA$568,398,026
American Heart Association (AHA)Dallas, TX$746,432,389
Nonprofit Types
Issues
Characteristics
Key performance indicators
Total revenues
$460,828,632
2019
Yearly growth
6.9%
% of revenues
n/a
Total expenses
$453,104,239
2019
Yearly growth
4.2%
% of expenses
n/a
Total assets
$269,396,199
2019
Yearly growth
6.1%
% of assets
n/a
Num. employees
1,452
2019
Yearly growth
10%
% of total
n/a
General information
Address
125 May Street
Edison, NJ 08837
Metro area
New York-Newark-Jersey City, NY-NJ-PA
Website URL
mtfbiologics.org/ 
Phone
(732) 661-0202
Twitter profile
@themtf1 
IRS details
EIN
22-2803458
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1987
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
E65: Organ and Tissue Bank
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Central organization